Haoyu Ye

3.0k total citations
119 papers, 2.5k citations indexed

About

Haoyu Ye is a scholar working on Molecular Biology, Organic Chemistry and Analytical Chemistry. According to data from OpenAlex, Haoyu Ye has authored 119 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 22 papers in Organic Chemistry and 21 papers in Analytical Chemistry. Recurrent topics in Haoyu Ye's work include Natural product bioactivities and synthesis (27 papers), Chromatography in Natural Products (21 papers) and Magnolia and Illicium research (17 papers). Haoyu Ye is often cited by papers focused on Natural product bioactivities and synthesis (27 papers), Chromatography in Natural Products (21 papers) and Magnolia and Illicium research (17 papers). Haoyu Ye collaborates with scholars based in China, United States and United Kingdom. Haoyu Ye's co-authors include Lijuan Chen, Aihua Peng, Minghai Tang, Jianhong Yang, Wenshuang Wu, Yuquan Wei, Heying Pei, Shucai Li, Lun Wang and Xiaoying Cai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Haoyu Ye

118 papers receiving 2.5k citations

Peers

Haoyu Ye
Haoyu Ye
Citations per year, relative to Haoyu Ye Haoyu Ye (= 1×) peers Minghai Tang

Countries citing papers authored by Haoyu Ye

Since Specialization
Citations

This map shows the geographic impact of Haoyu Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoyu Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoyu Ye more than expected).

Fields of papers citing papers by Haoyu Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoyu Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoyu Ye. The network helps show where Haoyu Ye may publish in the future.

Co-authorship network of co-authors of Haoyu Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Haoyu Ye. A scholar is included among the top collaborators of Haoyu Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoyu Ye. Haoyu Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Minghai, Jie Wu, Neng Ye, et al.. (2025). Mechanisms and therapeutic strategies for NLRP3 degradation via post-translational modifications in ubiquitin-proteasome and autophagy lysosomal pathway. European Journal of Medicinal Chemistry. 289. 117476–117476. 2 indexed citations
2.
3.
Ye, Neng, Jie Wu, Min Zhao, et al.. (2025). Valtrate alleviates inflammation by targeting USP9X to enhance NLRP3 degradation. Phytomedicine. 143. 156835–156835. 1 indexed citations
4.
Tang, Minghai, Rui Wu, Jiajia Zhao, et al.. (2023). UPLC-MS/MS method development and application to pharmacokinetic study in rats and dogs of Flonoltinib Maleat. Journal of Chromatography B. 1223. 123696–123696. 2 indexed citations
5.
Cai, Xiaoying, Lun Wang, Mingsong Shi, et al.. (2023). Discovery of pyrimidine-5-carboxamide derivatives as novel salt-inducible kinases (SIKs) inhibitors for inflammatory bowel disease (IBD) treatment. European Journal of Medicinal Chemistry. 256. 115469–115469. 4 indexed citations
6.
Chen, Yong, Yuan Xue, Baojian Xiong, et al.. (2023). Discovery of Potent and Selective Phosphatidylinositol 3-Phosphate 5-Kinase (PIKfyve) Inhibitors as Methuosis Inducers. Journal of Medicinal Chemistry. 67(1). 165–179. 9 indexed citations
7.
Yang, Tao, Ailin Zhao, Mingsong Shi, et al.. (2022). Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2V617F-induced myeloproliferative neoplasms. Blood Cancer Journal. 12(3). 37–37. 9 indexed citations
8.
Li, Yong, Yan Liu, Wei Yan, et al.. (2022). Structure-Based Design and Synthesis of N-Substituted 3-Amino-β-Carboline Derivatives as Potent αβ-Tubulin Degradation Agents. Journal of Medicinal Chemistry. 65(3). 2675–2693. 19 indexed citations
9.
Zhang, Ruijia, Hong Feng, Min Zhao, et al.. (2022). New Highly Potent NLRP3 Inhibitors: Furanochalcone Velutone F Analogues. ACS Medicinal Chemistry Letters. 13(4). 560–569. 7 indexed citations
10.
Yang, Jianhong, Yong Li, Qiang Qiu, et al.. (2022). Small Molecules Promote Selective Denaturation and Degradation of Tubulin Heterodimers through a Low-Barrier Hydrogen Bond. Journal of Medicinal Chemistry. 65(13). 9159–9173. 9 indexed citations
11.
Wang, Lun, Yunhua Zheng, Dan Li, et al.. (2021). Design, Synthesis, and Bioactivity Evaluation of Dual-Target Inhibitors of Tubulin and Src Kinase Guided by Crystal Structure. Journal of Medicinal Chemistry. 64(12). 8127–8141. 25 indexed citations
12.
Qiu, Qiang, Minghai Tang, Peng Bai, et al.. (2021). Discovery of a Series of Hydroxamic Acid-Based Microtubule Destabilizing Agents with Potent Antitumor Activity. Journal of Medicinal Chemistry. 64(20). 15379–15401. 14 indexed citations
13.
Yang, Jianhong, Yamei Yu, Yong Li, et al.. (2021). Cevipabulin-tubulin complex reveals a novel agent binding site on α-tubulin with tubulin degradation effect. Science Advances. 7(21). 48 indexed citations
14.
Pei, Heying, Linlin Xue, Minghai Tang, et al.. (2020). Alkaloids from Black Pepper (Piper nigrum L.) Exhibit Anti-Inflammatory Activity in Murine Macrophages by Inhibiting Activation of NF-κB Pathway. Journal of Agricultural and Food Chemistry. 68(8). 2406–2417. 63 indexed citations
15.
Ma, Xu, Min Zhao, Minghai Tang, et al.. (2020). Flavonoids with Inhibitory Effects on NLRP3 Inflammasome Activation from Millettia velutina. Journal of Natural Products. 83(10). 2950–2959. 22 indexed citations
16.
Qiu, Qiang, Minghai Tang, Fang Wang, et al.. (2019). Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL –Induced B-Cell Acute Lymphoblastic Leukemia. Clinical Cancer Research. 25(24). 7527–7539. 16 indexed citations
17.
18.
Zhao, Min, Haoyu Ye, Aihua Peng, et al.. (2019). Anti-inflammatory Ellagitannins from Cleidion brevipetiolatum for the Treatment of Rheumatoid Arthritis. Journal of Natural Products. 82(9). 2409–2418. 21 indexed citations
19.
Wang, Fang, Li Zheng, Zhuang Yang, et al.. (2018). SKLB-23bb, A HDAC6-Selective Inhibitor, Exhibits Superior and Broad-Spectrum Antitumor Activity via Additionally Targeting Microtubules. Molecular Cancer Therapeutics. 17(4). 763–775. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026